As the widespread adoption of GLP-1 receptor agonists reshapes the treatment landscape for obesity and metabolic disease, a new and arguably more intricate challenge is emerging: guiding patients through the phase that follows with GLP-1 nutritional support. The discontinuation of GLP-1 therapy is not merely the end of pharmacologic appetite suppression; it represents a critical metabolic inflection point, where compensatory physiology can rapidly unravel previous progress if left unchecked.1,2 What follows is far from benign. Appetite mechanisms recalibrate, often overshooting…

By: Yekta Dowlati, PhD GLP-1 receptor agonists (GLP-1 RAs), including semaglutide and liraglutide, have redefined therapeutic strategies for type 2 diabetes and obesity by harnessing incretin biology to achieve profound metabolic benefits.1 These agents enhance glucose-dependent insulin secretion, suppress glucagon, delay gastric emptying, and reduce appetite through central and peripheral pathways. However, the same physiological mechanisms that underpin their efficacy are intrinsically linked to gastrointestinal (GI) side effects—an area of growing clinical significance.2 Nausea, early satiety, bloating, diarrhea, and constipation…

By: Yekta Dowlati, PhD The advent of GLP-1 receptor agonists (GLP-1 RAs) marks a transformative era in obesity and type 2 diabetes management. As of 2024, 6% of adults in the United States are currently using GLP-1 medications, with 12% reporting either current or previous use.1 Among those who have been diagnosed with overweight or obesity by a healthcare provider, this figure increases to 22%.1 These agents—such as semaglutide and tirzepatide—deliver clinically meaningful weight loss, improved glycemic control, and cardiovascular…

by Yekta Dowlati, PhD In today’s fast-paced world, maintaining optimal health and vitality can feel overwhelming. With constant demands on energy, mood, digestion, and metabolism, many people struggle to feel their best. For women, these challenges can be even more complex due to hormonal fluctuations, evolving health needs, and busy lifestyles. But what if the key to lasting well-being lies in science-backed, natural ingredients? Research shows that targeted bioactive compounds—derived from plants and essential minerals—can support the body’s natural ability…

by Kyle Perkovich, BS The gut, often referred to as the body’s “second brain,” is central to overall health, influencing everything from digestion to immune function, metabolism, and even mental health.1-3 Emerging research consistently demonstrates that a balanced and diverse gut microbiome is essential for overall health and a key aspect of every patient’s wellness. The gut microbiome – a complex ecosystem containing trillions of bacteria and other microorganisms – helps regulate digestion and communicates with various body systems through neurotransmitters,…

by Kyle Perkovich, BS In the intricate ecosystem of the human gut, a new frontier is emerging, marked by the strategic paring of probiotics and prebiotics working synergistically to help provide optimal gut health and well-being. This combination, known as synbiotics, is gaining prominence for its potential to enhance gut health and immune function. As research has advanced, the role of our gut microbiota has become increasingly recognized as a vital part of overall health, influencing not only proper digestion,…

We have compiled our most viewed blogs, webinars, and clinical tools on metabolic detoxification to help you keep up with the latest research on this topic that will enable you to help your patients’ live healthier, happier lives.

Patients with obesity suffer from chronic, low-grade inflammation.1 That’s partly due to dysfunctions in the ability to endogenously create specialized pro-resolving mediators (SPMs).1 SPMs communicate with immune cells, telling them the inflammatory process is no longer needed and to finish the job.2 However, in many conditions, including obesity, the capability to send these potent signaling molecules can diminish, and so too can their effects.1-3 As a result, inflammation smolders and further perpetuates a vast array of associated conditions such as…

Menopause can be a serious disruption to a woman’s life. For decades, women and their doctors have turned to hormone replacement and nonhormonal therapies to seek relief. Many women prefer not to take hormones, or for various reasons hormones present a specific health risk, taking them off the table for therapy. A plant extract (ERr 731), made from Siberian rhubarb (Rheum rhaponticum) has been in use for treating menopause in Europe since the 1990s and is now gaining momentum in…

Hormone replacement therapy (HRT) is a mainstay for treating menopause, but more and more women are searching for non-hormonal therapies. An extract from Siberian Rhubarb (latin name Rheum rhaponticum) has been in use treating menopause for decades, and is now gaining popularity in more markets worldwide. Recently (2021) another clinical trial demonstrated the efficacy and safety of this extract, ERr-731, in treating menopause in Indian women.1 In this Indian trial researchers found a 4 mg once daily dose led to…